The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2023 | Unmet needs for gallbladder cancers
Sushma Agrawal, MD, SGPGI, Lucknow, India, comments on the unmet needs of bladder cancer. Despite the observed improvement in overall-survival (OS), it is acknowledged that current treatments are not optimal. There is a need for further advancements in the field. A recent publication of immunotherapy results suggests that combining radiotherapy with immunotherapy should be explored in prospective studies. The aim is to investigate if this combination can yield better outcomes compared to the current approach of consolidation chemotherapy and radiation. Dr Agrawal emphasizes the importance of ongoing research and development to address the unmet needs in gallbladder cancer treatment. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Annual Congress in Chicago, IL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
